Five Years In, MDI Bio Lab's Chemical Database Finds Friend in Pfizer

Dr. Carolyn Mattingly of the Mount Desert Island Biological Laboratory has been awarded $882,000 from the pharmaceutical giant Pfizer to investigate 1,500 chemical compounds that may be useful in drug development by using the Comparative Toxicogenomics Database (CTD), a massive public database that she and her team developed at MDIBL.  Pfizer’s funding is important recognition of the critical role CTD can play in finding new targets for pharmaceuticals and predicting drug toxicity.

Ezra Silk talks with Dr. Mattingly and gives an overview of CTD in this article.